clinicians preference when semaglutide is not suitable Understanding (GLP-1 RA): Are they the right choice for weight loss? Semaglutide for the treatment of

Zubair, S.H

INDIANAPOLIS A clinical trial led by an Indiana University School of Medicine researcher found that weekly doses of semaglutide a medication typically prescribed to Type 2 diabetes patients improved blood sugar levels and weight loss for adult Type 1 diabetes patients who use automated insulin delivery systems and have a body mass index of 30 or higher

In people with type 2 diabetes, this incretin effect is significantly reduced

& Zariwala, M

Within minutes of the infusion, the patients reportedly experienced symptoms of varying degrees, including nausea, vomiting, lightheadedness, chills, body aches and sneezing